Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Aptamer Proteomics for Biomarker Discovery in Heart Failure with Reduced Ejection Fraction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Genetic Variants Close to TTN, NKX2-5, and MYH6 Associate With AVNRT

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Posterior wall isolation in persistent atrial fibrillation feasibility, safety, durability, and efficacy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Left atrial contractile strain predicts recurrence of atrial tachyarrhythmia after catheter ablation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Karl Georg Haeusler
  • Felizitas A Eichner
  • Peter U Heuschmann
  • Jochen B Fiebach
  • Tobias Engelhorn
  • Benjamin Blank
  • David Callans
  • Arif Elvan
  • Massimo Grimaldi
  • Jim Hansen
  • Gerhard Hindricks
  • Hussein R Al-Khalidi
  • Lluis Mont
  • Jens Cosedis Nielsen
  • Jonathan P Piccini
  • Ulrich Schotten
  • Sakis Themistoclakis
  • Johan Vijgen
  • Luigi Di Biase
  • Paulus Kirchhof
Vis graf over relationer

BACKGROUND: We aimed to assess the prevalence of ischemic brain lesions detected by magnetic resonance imaging and their association with cognitive function 3 months after first-time ablation using continuous oral anticoagulation in patients with paroxysmal atrial fibrillation (AF).

METHODS: We performed a prespecified analysis of the AXAFA-AFNET 5 trial (Anticoagulation Using the Direct Factor Xa Inhibitor Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy), which randomized 674 patients with AF 1:1 to uninterrupted apixaban or vitamin K antagonist therapy before first-time ablation. Brain magnetic resonance imaging using fluid-attenuated inversion recovery and high-resolution diffusion-weighted imaging was obtained within 3 to 48 hours after AF ablation in all eligible patients enrolled in 25 study centers in Europe and the United States. Patients underwent cognitive assessment 3 to 6 weeks before ablation and 3 months after ablation using the Montreal Cognitive Assessment (MoCA).

RESULTS: In 84 (26.1%) of 321 patients with analyzable magnetic resonance imaging, high-resolution diffusion-weighted imaging detected at least 1 acute brain lesion, including 44 (27.2%) patients treated with apixaban and 40 (24.8%) patients treated with vitamin K antagonist (P=0.675). Median MoCA score was similar in patients with or without acute brain lesions at 3 months after ablation (28 [interquartile range (IQR), 26-29] versus 28 [IQR, 26-29]; P=0.948). Cerebral chronic white matter damage (defined as Wahlund score ≥4 points) detected by fluid-attenuated inversion recovery was present in 130 (40.5%) patients and associated with lower median MoCA scores before ablation (27 [IQR, 24-28] versus 27 [IQR, 25-29]; P=0.026) and 3 months after ablation (27 [IQR, 25-29] versus 28 [IQR, 26-29]; P=0.011). This association was no longer significant when adjusted for age and sex. Age was associated with lower MoCA scores before ablation (relative risk, 1.02 per 10 years [95% CI, 1.01-1.03]) and 3 months after ablation (relative risk, 1.02 per 10 years [95% CI, 1.01-1.03]).

CONCLUSIONS: Chronic white matter damage as well as acute ischemic lesions detected by brain magnetic resonance imaging were found frequently after first-time ablation for paroxysmal AF using uninterrupted oral anticoagulation. Acute ischemic brain lesions detected by high-resolution diffusion-weighted imaging were not associated with cognitive function at 3 months after ablation. Lower MoCA scores before and after ablation were associated only with older age, highlighting the safety of AF ablation on uninterrupted oral anticoagulation.

REGISTRATION: URL: https://www.

CLINICALTRIALS: gov; Unique identifier: NCT02227550.

OriginalsprogEngelsk
TidsskriftCirculation
Vol/bind145
Udgave nummer12
Sider (fra-til)906-915
Antal sider10
ISSN0009-7322
DOI
StatusUdgivet - 22 mar. 2022

ID: 79294091